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Summary
Objective
The objective of this research is to study effects of a 4-week high-protein (HP) diet on
energy intake, resting energy expenditure (REE), protein turnover and body composition
in children with obesity.
Methods
In this randomized placebo-controlled single-blind crossover study, children with obesity
(n = 14; mean age: 10.1 years ± 1.2 standard deviation; body mass index–standard
deviation score [BMI-SDS]: 2.8 ± 0.5) received an ad libitum HP (+50 g protein per day)
or normal-protein (NP) diet for 4 weeks with a washout period of ≥2 weeks. Energy intake,
REE, protein turnover, weight, BMI-SDS and body composition were measured.
Results
No differences were found in energy intake or REE between HP and NP. There was an
increased urea production and phenylalanine hydroxylation after HP compared with NP
(p < 0.05). There was an increased rise in fat-free mass after HP compared with NP
(ΔHP: 0.8 ± 0.8 kg vs. ΔNP: 0.1 ± 0.6 kg, p < 0.05). BMI and BMI-SDS increased during
the study (BMI-SDS start: 2.8 ± 0.5, end: 2.9 ± 0.5, p < 0.05) without a difference
between groups.
Conclusions
A 4-week HP diet with ad libitum food intake did not affect energy intake and energy
expenditure in children with obesity. BMI increased, although that could be partly
explained by an increase in fat-free mass.
Keywords: Body composition, dietary protein, energy expenditure, protein turnover.
Introduction
The prevalence of childhood overweight and obesity is
high. Currently, about 25–30% of the children in Europe
and the USA are overweight and 5–15% are obese (1–3).
Children with obesity are likely to become overweight or
obese adults, with an increased risk of type 2 diabetes
mellitus, cardiovascular disease and certain types of
cancer (4–6). Already among children with obesity, there
is a rising prevalence of the metabolic syndrome (7,8).
Thus, effective strategies for weight loss and weight
maintenance in children are needed.
In adults, randomized controlled trials with diet
interventions using a high-protein (HP) intake have shown
increased weight loss and improved weight maintenance
after weight loss (9). Several metabolic targets have been
shown to be affected by an HP diet: (1) suppressed
appetite and reduced energy intake (10,11), (2) increased
energy expenditure (12–15) and (3) preservation of
fat-free mass (FFM) (16,17). The mechanism via which
an HP diet affects metabolic targets like energy expendi-
ture and preservation of FFMmay be an increased protein
and amino acid metabolism (10,18). The body has no
storage capacity to cope with HP intake and therefore
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has to metabolize it immediately. Gluconeogenesis has a
major contribution to increased energy expenditure at an
HP diet (19); however, the extent to which processes of
protein metabolism, e.g. protein synthesis and protein
oxidation, are actually affected by a relatively HP intake
is not clear yet (13,20). Stable isotope techniques allow
assessment of protein synthesis and breakdown as well
as gluconeogenesis (21), and these will add to the
understanding of what metabolic processes are affected
by an HP diet.
With regard to children with overweight or obesity,
some studies have focused on the effects an HP intake
on weight loss and weight maintenance. In a large
European study with 827 children, it was shown that an
HP diet in combination with a low glycaemic index was
protective against obesity (22). Other studies have shown
less effects of an HP intake on body weight in children
with overweight or obesity (23–25). Thus, the results of
studies in children with obesity are inconclusive. How-
ever, before a long-term study focusing on body weight
can be conducted, first, a short-term pilot study is needed
to study which metabolic targets are affected by an HP
intake in children with obesity. To the best of our knowl-
edge, there are no studies that have assessed the effect
of an HP diet on metabolic targets in children with obesity
using different types of high-quality and well-validated
techniques, like indirect calorimetry and stable isotope
techniques. In the present study, the objective was to
study the effects of a 4-week HP intake on energy intake,
energy expenditure, protein turnover and body composi-
tion, i.e. fat mass and FFM, in children with obesity. The
aim was to increase protein intake with approximately
50 g d1 to reach an HP intake of ≥20% of energy, which
generally is regarded as HP intake (9). The HP intake was
applied via two HP supplements daily, in addition to ad
libitum food intake. It was hypothesized that the HP
supplements increased satiety, resulting in a lower ad
libitum food intake from the regular diet. Altogether, it
was hypothesized that, similarly to what has been shown
in adults, an HP intake may have beneficial effects on
energy intake, energy expenditure and body composition
for children with obesity and may contribute to obtaining
a healthy body weight.
Methods
Subjects
This study was conducted in two academic hospitals in
the Netherlands: the Erasmus MC–Sophia Children’s
Hospital in Rotterdam and the VU University Medical
Center in Amsterdam. Inclusion criteria were obesity (body
mass index–standard deviation score [BMI-SDS] > 2.0),
prepubertal according to the classification of Tanner,
aged between 8 and 12 years and motivation to partici-
pate in the study of both the child and his or her parents.
Exclusion criteria were obesity caused by a somatic
treatable disorder or use of systemic steroids. The
paediatrician checked the inclusion and exclusion criteria,
and eligible children and their parents were subsequently
informed about the study by the researcher. Motivation
to participate in the study was assessed by the paediatri-
cian based on his or her experiences with the family. The
children and parents had visited the paediatrician and
other disciplines in the hospital in the preceding months
on several occasions because of the obesity the child
suffered. The study was presented to the child and the
parents as a trial studying potential beneficial effects of
an HP intake, which in the end could be helpful for
treatment and prevention strategies for children with
obesity. Informed consent was obtained from the parents
of all participants. The study was approved by theMedical
Ethics Committee of the Erasmus MC. Participants were
recruited from January 2011 to June 2014; the children
were enrolled in the study one by one, and studymeasure-
ments took place from May 2011 to September 2014. In
general, the children attended school during the study;
however, for some of the children, part of the study took
part during a school holiday.
Study design
The study had a randomized placebo-controlled single-
blind crossover design with 4 weeks of an HP diet and
4 weeks of a normal-protein (NP) diet separated by a
washout period of at least 2 weeks. For practical schedul-
ing reasons, the washout period could last more than
2 weeks. One group of subjects received the diets in the
order HP–NP (group 1), and the other group of subjects
received the diets in the order NP–HP (group 2). The
allocation sequence was generated using computerized
randomization.
On day 0 and day 28 of both intervention periods (NP0,
NP28, HP0 and HP28), the children came to the research
unit. They underwent a series of measurements in the
fasted state including anthropometrics, body composi-
tion, resting energy expenditure (REE), appetite and
measurement of protein turnover using stable isotope
techniques. Measurements took place at similar times on
each test day, with t = 0 min referring to baseline blood
sampling and t = 360 min to collection of the final blood
samples. Other measurements took place between these
time points.
The children kept a daily compliance diary during the
intervention periods, and the children and their parents
were in contact with the researchers by e-mail and/or
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telephone once per 3 or 4 d. In the compliance diary, the
children reported whether they consumed both supple-
ments. The compliance diaries were discussed during
the e-mails/phone calls and on day 28 of both interven-
tion periods. This was to support compliance and to
obtain an impression on the level of supplement intake.
No quantitative data on compliance to the supplements
were collected or analysed.
Diets
In both HP and NP, the children consumed their ad libitum
habitual diets and two supplements per day.
The protein supplement was offered as protein powder
(Protifar Plus®, Nutricia, The Netherlands), which was
processed into a milkshake using (fruit) yoghurt or
chocolate milk. The children were provided with a list of
recipes in order to prepare a milkshake with a taste the
child preferred most. Depending on the recipe, the HP
milkshakes contained between 179 and 189 kcal and
24.9–27.7 g protein, 5.6–17.3 g carbohydrates and
0.8–4.4 g fat per milkshake. When the children were on
the NP diet, they consumed two iso-energetic milkshakes
containing a carbohydrate and fat powder (Duocal®,
Nutricia, The Netherlands) that was combined with fruit
juice or fruit sauce and processed into a milkshake.
Again, the children were provided with a list of recipes.
Depending on the recipe, the NP milkshakes contained
between 177 and 182 kcal and 0.2–1.3 g protein, 32.5–
34.8 g carbohydrates and 4.5–4.8 g fat per milkshake.
The milkshakes were consumed at the start of the break-
fast and at the start of the dinner. The children were
instructed to first consume the entire milkshake and after
that to continue with the rest of normal breakfast or
dinner, respectively, and consume as much or little from
the meal as they preferred (i.e. ad libitum). In the washout
period, the children ate their habitual diet ad libitum and
did not receive supplements. The powder supplements
were weighted into two daily portions by one of the
researchers, while the children and their caregivers were
blinded to the treatment.
Measurements
Energy intake and appetite
The children kept a 3-d food diary on three consecutive
days (two weekdays and one weekend day) in week 3 of
both intervention periods. On day 28 of both intervention
periods, the children were interviewed by a trained
researcher in order to cross-check the food diaries. The
parents assisted their children with keeping the diary
and with the interview. The results of the interview were
analysed for energy and macronutrient intake using the
computerized nutritional tables of the Erasmus MC. The
reported energy intake was compared with the measured
REE, and a value of <1.3 was considered as
underreporting and excluded from further analysis (26).
Appetite, i.e. hunger, fullness, desire to eat and
prospective consumption, was rated on 100-mm visual
analogue scales, anchored with ‘not at all’ and ‘extremely’
on each test day at time point t = 150 min.
Energy expenditure (indirect calorimetry)
The REE and respiratory quotient were calculated from the
measurements of O2 consumption and CO2 production
for 20 min using a ventilated hood system (Datex Division
Instrumentarium, Finland). The formula of Brouwer (27)
was used to calculate energy expenditure; urinary
nitrogen excretion was neglected in the calculation.
Body weight and body composition
Body weight and height were measured, and subsequently,
BMI (in kg m2) was calculated. BMI-SDS was calculated
with the software programme Growth Analyser ver-
sion 3 (Dutch Growth Foundation, Rotterdam, The
Netherlands; www.growthanalyser.org). Body fat and
FFM were measured using dual-energy X-ray absorp-
tiometry (DEXA). Each scan of each child was made
on the same machine (Lunar Prodigy, GE Healthcare
at the Erasmus MC and Hologic Discovery at the VU
University Medical Center) by a trained professional.
The fat mass index (FMI) and the fat-free mass index
(FFMI, in kg m2) were calculated.
Stable isotope techniques: protein turnover and
glucose production
In order to calculate the amount of stable isotopes to be
infused, the FFM was estimated using the formula of
Deurenberg et al. (28) estimating that total body water
was 73% of FFM.
On days 0 and 28 of both intervention periods, a
Venflon catheter (Becton Dickinson, Franklin Lakes, NJ,
USA) was placed in a superficial dorsal vein of the hand
for blood sampling and another Venflon catheter was
placed in a superficial vein of the other arm for intrave-
nous infusion. A 6-h-primed continuous infusion of a
mixture of stable isotopes (obtained from Cambridge
Isotopes, Andover, MA, USA) was started after baseline
blood sampling (t = 0). [ring-2H5]Phenylalanine (98%
enriched; prime: 5 μmol kg1 FFM; continuous:
3 μmol kg1 FFM h1), [3,3-2H2]tyrosine (98% enriched;
prime: 2 μmol kg1 FFM; continuous: 2 μmol kg1 FFM
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h1) and [ring-2H4]tyrosine (98% enriched; prime:
0.7 μmol kg1 FFM) were used to measure protein oxida-
tion and synthesis, and [15N2]urea (98% enriched; prime:
40 μmol kg1 FFM; continuous: 4 μmol kg1 FFM h1)
was used for measurement of urea production. [6,6-2H2]
Glucose (99% enriched; prime: 22 μmol kg1 FFM;
continuous: 20 μmol kg1 FFM h1) and oral 2H2O
(99.9% enriched, Eurisotop, Saint-Aubin Cedex, France;
5 g kg1 body water) were used to measure endogenous
glucose production and gluconeogenesis. The 2H2O was
consumed hourly between 60 and 180 min. At 240, 300
and 360 min, blood samples were taken to measure en-
richment of [2H5]phenylalanine, [
2H2]tyrosine, [ring-
2H4]ty-
rosine, [15N2]urea, [
2H2]glucose, [6,6-
2H2]glucose and
plasma 2H2O enrichment.
Stable isotope techniques: gas chromatography,
mass spectrometry and calculations
Blood samples were centrifuged for 10 min at 3,500g, and
plasma was stored at 80°C until further analysis.
Plasma isotopic enrichments of [ring-2H5]phenylala-
nine, [3,3-2H2]tyrosine and [ring-
2H4]tyrosine were deter-
mined by gas chromatography–mass spectrometry
(GC-MS) (Agilent 5975C GC-MS, Agilent Technologies,
Amstelveen, The Netherlands) after using the
N-ethoxycarbonyl ethyl ester derivative according to a
modified method of Husek (29).
Plasma urea enrichment was determined by GC-MS
(Agilent 5975C GC-MS, Agilent Technologies) as
described by Vlaardingerbroek et al. (30).
Enrichments of glucose labelled with 2H were mea-
sured by GC-MS (Agilent 5975C, Agilent Technologies,
Wilmington, DE, USA) using the penta-acetate derivative
as previously described (31). Plasma isotopic enrichment
of [6,6-2H2]glucose (M+2) was determined by monitoring
fragment ions at a mass-to-charge ratio (m/z) of 169
and 171. Selective ion monitoring of m/z 170/169
was performed to determine the M+1 enrichment of
deuterium in the circulating glucose carbons (C-1, 3, 4,
5, 6, 6) (31).
Isotopic enrichment of deuterium in plasma body
water was determined by isotope ratio mass spectro-
metry (DeltaPlus XP IRMS, Thermo Fisher, Bremen,
Germany).
Whole body protein kinetics, urea production and
endogenous glucose production were calculated by
conventional isotope dilution equations using a model
during steady-state enrichment (21,32). Phenylalanine
hydroxylation (rate of phenylalanine conversion into
tyrosine) was calculated as described by Marchini et al.
(33,34). Fractional gluconeogenesis was calculated using
the average deuterium enrichment method (31).
Statistical analysis
The Shapiro–Wilk normality test was used to determine
whether data were normally distributed. Data are
presented as mean ± standard deviation unless otherwise
indicated. For the variables energy intake, macronutrient
intake, appetite, REE, respiratory quotient, protein
turnover, endogenous glucose production, body weight
and body composition comparisons between delta HP
and delta NP, i.e. ΔHP = HP28–HP0 and ΔNP = NP28–
NP0, and between HP28 and NP28 were made using a
paired t-test if normally distributed or a Wilcoxon signed
rank test if not normally distributed. A p-value < 0.05
was considered as statistically significant. Statistical pro-
cedures were performed using SPSS version 20 (IBM
SPSS Statistics, Chicago, IL, USA).
Results
Subjects
The flow chart of this study is presented in Figure 1.
Eighteen healthy children (nine boys and nine girls) with
obesity were randomized to participate in the study;
baseline characteristics are described in Table 1. Four
subjects dropped out of the study leaving 14 subjects
who completed the study: eight boys and six girls with a
mean age at start of the study of 10.1 ± 1.2 years, body
weight of 60.06 ± 13.42 kg, height of 1.45 ± 0.09 m,
BMI of 28.4 ± 4.2 kg m2 and BMI-SDS of 2.8 ± 0.5.
Eleven children participated at the Erasmus MC–Sophia
Children’s Hospital, and three participated at the VU
University Medical Center. There were no significant
differences in age, sex or BMI-SDS at baseline between
those who did and did not complete the study. The rea-
son for not completing the study was loss of motivation
to comply with the study requirements, i.e. to consume
two milkshakes per day and to undergo the assessments,
during the washout period (n = 1) and loss of motivation
during HP (n = 3); all were subjects in group 2. There were
no significant differences at baseline between subjects in
group 1 and subjects in group 2. The mean washout
period was 5 ± 2 weeks, with a minimum of 3 weeks
and a maximum of 9 weeks.
Energy and macronutrient intake, compliance and
appetite
Energy intake was considered as underreported in three
children and left out of analysis in two cases during HP
and two during NP. The energy and macronutrient intake
is presented in Table 2. Protein intake was 21% ± 3% of
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energy during HP, indicating a successful intervention to
reach an HP intake.
There was no quantitative data collection or analysis
from the compliance diaries. In general, the children
indicated that they consumed the milkshakes entirely
and that on a few occasions they forgot to take the
milkshakes. All in all the compliance diaries showed a
good compliance to milkshakes without major differences
between HP and NP.
There were no differences in hunger, fullness, desire to
eat and prospective consumption as measured with
100-mm visual analogue scales between HP and NP
(Table 3).
Resting energy expenditure and respiratory
quotient
The REE was 1,575 ± 264 and 1,574 ± 247 kcal/24 h
at HP0 and HP28, respectively, and 1,595 ± 239
and 1,590 ± 256 kcal/24 h at NP0 and NP28, respec-
tively. There were no differences in REE between HP
and NP.
The respiratory quotient was 0.80 ± 0.07 and
0.79 ± 0.07 at HP0 and HP28, respectively, and
0.81 ± 0.05 and 0.80 ± 0.06 at NP0 and NP28, respec-
tively. There were no differences in respiratory quotient
between HP and NP.
Figure 1 Flow chart of the randomized placebo-controlled single-blind crossover study on the effects of a 4-week high-protein intake in children
with obesity. M, male; F, female.
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Protein turnover and endogenous glucose
production
Protein turnover and endogenous glucose production
were measured in a subgroup of n = 8 children from the
Erasmus MC–Sophia Children’s Hospital who had data
available for all four study visits. There were no significant
differences in age, BMI, BMI-SDS or body composition
between this subgroup and the total study population.
There were no significant differences between HP0 and
NP0. Ra urea, Ra tyrosine and the phenylalanine hydrox-
ylation were increased at HP28 compared with NP28
(Table 4). In addition, the phenylalanine balance was
more negative at HP28 compared with NP28. There
were no differences in endogenous glucose production
or fractional gluconeogenesis between HP and NP
(Table 4).
Body weight and body composition
When analysed together, regardless of the type of diet,
body weight and BMI increased significantly during
participation in the study, which had an average duration
of 13 ± 1 weeks. At the start of the study, body weight
was 60.06 ± 13.42 kg, and it was 62.82 ± 14.24 kg at
the end of the study (p < 0.001; BMI start:
28.4 ± 4.2 kg m2, end: 29.3 ± 4.5 kg m2, p < 0.01). This
resulted in a significant increase in BMI-SDS (start:
2.8 ± 0.5, end: 2.9 ± 0.5, p < 0.05). The increase in body
weight and BMI was significantly larger in the second in-
tervention period compared with the first intervention pe-
riod (body weight Δ1st intervention period: 0.86 ± 0.95 kg
vs. Δ2nd intervention period: 1.5 ± 0.67 kg, p < 0.05; BMI
Δ1st intervention period: 0.2 ± 0.6 kg m2 vs. Δ2nd
intervention period: 0.6 ± 0.4 kg m2, p < 0.05).
When analysed for HP and NP separately, body weight
and BMI increased significantly during HP and during NP
(Table 5). There were no significant differences in body
weight, BMI or BMI-SDS between HP and NP (Table 5).
For practical reasons, DEXA scans were not available
in several occasions. Therefore, only data of the children
with DEXA scans on all four occasions (n = 10) were
analysed. Both during HP and during NP, fat mass and
FMI increased significantly (Table 5). In addition, during
HP, FFM and FFMI increased significantly (Table 5), and
delta FFM and delta FFMI were increased during HP
compared with NP (Table 5).
Discussion
This study showed that a diet intervention with a 4-week
HP intake did not affect ad libitum energy intake, appetite
or REE in children with obesity. Body weight, BMI and
BMI-SDS as well as the fat mass and FMI of the children
increased significantly during the study period. However,
during the HP diet, the FFM and the FFMI also increased,
which may partly explain the increase in BMI during the
HP diet. FFM, of which muscle mass is the major
Table 1 Baseline characteristics of subjects enrolled in a random-
ized placebo-controlled single-blind crossover study with a 4-week
high-protein intake (n = 18)
Group 1 (n = 10) Group 2 (n = 8)
M/F 5/5 4/4
Age (year) 10.0 ± 1.1 10.2 ± 1.5
Body weight (kg) 57.34 ± 6.58 59.17 ± 17.73
Height (m) 1.44 ± 0.09 1.45 ± 0.10
BMI (kg m2) 27.7 ± 3.4 27.7 ± 4.8
BMI-SDS 2.7 ± 0.4 2.7 ± 0.6
Treatment order: high-protein diet–normal-protein diet (group 1);
normal-protein diet–high-protein diet (group 2).
BMI, body mass index; F, female; M, male.
Table 2 Energy and macronutrient intake during a randomized
placebo-controlled single-blind crossover study with a 4-week
high-protein intake in children with obesity (n = 12)
Normal-protein diet High-protein diet
Energy (kcal d1) 2,156 ± 252 2,311 ± 292
Protein (g d1) 72 ± 24 120 ± 15**
Protein (En%) 13 ± 3 21 ± 3**
Fat (g d1) 81 ± 15 78 ± 17
Fat (En%) 34 ± 3 30 ± 5*
Carbohydrate (g d1) 283 ± 32 283 ± 48
Carbohydrate (En%) 53 ± 5 49 ± 5
*Significant difference between high-protein diet and normal-protein
diet, p < 0.05 paired t-test.
**Significant difference between high-protein diet and normal-protein
diet, p < 0.01 paired t-test.
Table 3 Appetite ratings in the fasted state measured with 100-mm
visual analogue scales during a randomized placebo-controlled
single-blind crossover study with a 4-week high-protein intake in
children with obesity (n = 14)
Normal-protein diet High-protein diet
Day 0 Day 28 Day 0 Day 28
Hunger (mm) 57 ± 27 68 ± 25 50 ± 28 61 ± 37
Fullness (mm) 21 ± 24 17 ± 19 17 ± 19 13 ± 16
Desire to eat (mm) 53 ± 34 63 ± 31 52 ± 30 52 ± 35
Prospective
consumption (mm)
52 ± 21 59 ± 28 57 ± 27 60 ± 32
No significant differences between NP0 and NP28 and between HP0
and HP28.
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component, determines energy expenditure to a much
greater extent than fat mass does. In the long term, an in-
crease in muscle mass may have a significant effect on
energy expenditure (35). The sparing of FFM with an HP
diet during weight loss or weight maintenance after
weight loss has been shown before (16,17,36); the pres-
ent study shows that an HP diet increases FFM during
weight gain. The small but significant increase in FFM af-
ter the HP diet may in the long term result in increased en-
ergy expenditure and less metabolic disturbances.
However, the present study showed no such a benefit in
the short term. The overall weight gain during the study
period can be explained by a higher energy intake as
compared with the energy needs, which is likely to be at
least partly explained by the absence of compensation
of energy intake from normal food intake.
Several studies in adults did observe effects of an
HP diet on metabolic targets (10–17,19,37). The
amount of protein the children consumed in the present
study in the HP diet (21 En%) was similar to most of the
studies in adults. The lack of beneficial effects on
appetite, energy intake or energy expenditure may partly
be explained by differences in timing in comparison
with previous studies. In the present study, appetite and
Table 4 Protein turnover and endogenous glucose production during a randomized placebo-controlled single-blind crossover study with a
4-week high-protein intake in children with obesity (n = 8)
Normal-protein diet High-protein diet
Day 0 Day 28 Delta Day 0 Day 28 Delta
Ra urea (μmol kg1 h1) 304 ± 46 284 ± 73 20.2 ± 65.5 319 ± 96 377 ± 62* 57.8 ± 86.9
Ra phenylalanine (μmol kg1 h1) 54.4 ± 12 44.7 ± 13 9.7 ± 15.8 55.1 ± 14 51.7 ± 8.3 3.3 ± 15.9
Ra tyrosine (μmol kg1 h1) 46.1 ± 12 37.7 ± 15 8.4 ± 11.4 45.7 ± 11 45.9 ± 9.9* 0.2 ± 10.5
Phenylalanine hydroxylation (μmol kg1 h1) 13 ± 4.8 9.4 ± 4.9 3.6 ± 5.7 13 ± 4.9 12.3 ± 3.5* 0.6 ± 6
Non-hydroxylation phenylalanine disposal
(μmol kg1 h1)
41.4 ± 7.4 35.3 ± 9.5 6.1 ± 10.8 42.1 ± 9.8 39.4 ± 6.5 2.7 ± 10.4
Phenylalanine balance (μmol kg1 h1) 13 ± 4.8 9.4 ± 4.9 3.6 ± 5.7 13 ± 4.9 12.3 ± 3.5* 0.6 ± 6
Endogenous glucose production (mg kg1 min1) 3.2 ± 0.3 2.9 ± 0.4 0.3 ± 0.5 3.2 ± 0.3 3.1 ± 0.3 0.1 ± 0.3
Fractional gluconeogenesis (%) 66 ± 14 69 ± 14 3 ± 10.0 63 ± 12 67 ± 6 4 ± 8
Delta: day 28 minus day 0.
No significant differences between NP0 and NP28 and between HP0 and HP28.
*Significant difference between day 28 high-protein diet and day 28 normal-protein diet, p < 0.05 paired t-test.
Table 5 Body weight and body composition a during a randomized placebo-controlled single-blind crossover study with a 4-week high-protein
intake in children with obesity (n = 14)
Normal-protein diet High-protein diet
Day 0 Day 28 Delta Day 0 Day 28 Delta
Body weight (kg) 61.04 ± 13.30 62.13 ± 13.43*** 1.1 ± 0.5 60.37 ± 13.99 61.60 ± 14.31** 1.23 ± 1.13
Body mass index (kg m2) 28.7 ± 4.2 29.0 ± 4.2** 0.3 ± 0.3 28.4 ± 4.5 28.9 ± 4.6* 0.4 ± 0.6
BMI-SDS 2.8 ± 0.5 2.9 ± 0.5 0.0 ± 0.1 2.8 ± 0.6 2.8 ± 0.5 0.1 ± 0.1
Body fat (%) 46.4 ± 4.3 47.3 ± 4.4 0.8 ± 1.2 46.3 ± 4.1 46.5 ± 4.5 0.2 ± 1.1
Body fat (kg) 29.6 ± 8.9 30.6 ± 8.8* 1.0 ± 0.9 29.1 ± 8.9 30.1 ± 9.2* 0.9 ± 0.9
Fat-free mass (kg) 33.4 ± 6.7 33.5 ± 6.9 0.1 ± 0.6 33.1 ± 7.5 33.9 ± 7.6* 0.8 ± 0.8*
Fat mass index (kg m2) 14.0 ± 3.2 14.4 ± 3.3* 0.4 ± 0.4 13.8 ± 3.3 14.1 ± 3.4* 0.4 ± 0.5
Fat-free mass index (kg m2) 15.8 ± 1.6 15.7 ± 1.7 0.1 ± 0.4 15.7 ± 1.9 16.0 ± 2.0* 0.3 ± 0.4*
Delta: day 28 minus day 0.
Body fat, fat-free mass, fat mass index and fat-free mass index were analysed in n = 10 children.
***p < 0.001 paired t-test/Wilcoxon signed rank test between day 28 and day 0 within a diet or between delta high-protein diet and
delta normal-protein diet.
**p < 0.01 paired t-test/Wilcoxon signed rank test between day 28 and day 0 within a diet or between delta high-protein diet and delta
normal-protein diet.
*p < 0.05 paired t-test/Wilcoxon signed rank test between day 28 and day 0 within a diet or between delta high-protein diet and delta
normal-protein diet.
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energy expenditure were measured in the fasted state
after 4 weeks on the diet whereas in other studies, it
was measured immediately after an HP meal (10) or
continuously while on an HP diet for 24–36 h (12–15).
Although considered to be very relevant, in the present
study, it was chosen not to add questionnaires to
complete at home, given that the burden for the
participants was already high.
Protein metabolism was measured using stable
isotope techniques to study which processes were
affected by an HP intake and could be affecting metabolic
targets like energy expenditure and body composition.
The results show increased protein oxidation after the
HP diet reflected by an increased urea production and
phenylalanine hydroxylation. Although not statistically
significant, the non-hydroxylation phenylalanine disposal
was also slightly increased after the HP diet. However,
the phenylalanine breakdown, i.e. the rate of appearance
of phenylalanine, was increased to a larger extent
resulting in a more negative phenylalanine balance, indi-
cating a higher protein breakdown than protein synthesis.
These results are in line with those of Pasiakos et al. who
also showed increased oxidation and a decreased net
balance with increased protein intake in overweight adults
(38). The increase in FFM during the HP diet suggests a
net increase in protein synthesis, which is in contrast with
the more negative phenylalanine balance. In our design,
we were not able to measure protein turnover in the
postprandial state. Therefore, we do not know whether
the increased protein intake may have resulted in a higher
protein synthesis during those periods. It can only be
speculated that the increase in FFM that was observed
during the HP diet can be explained by an increased
protein synthesis in the postprandial phase.
In the present study, no effects of the HP diet on
appetite or energy intake were observed. Studies that
did show a satiating effect of an HP intake have predom-
inantly been performed in adults. However, Lomenick
et al. have shown a short-term satiating effect of an HP
intake in children (39). In two longer-term studies with
HP diets in children with obesity, there was no effect on
appetite sensations (23,24). The potential satiating effect
of HP effect was not strong enough under ad libitum
conditions, i.e. when children are free to choose what,
when and how much to eat. Eating behaviour is deter-
mined by several internal and external cues, including
taste preferences, emotions and social factors (40).
Apparently, the effect of an HP diet was not as strong
as compared with all these other signals and the subjects
stayed in a positive energy balance during the study.
One of the limitations of the study is that the number of
subjects is relatively low. Unfortunately, the study
stopped before the planned number of 40 subjects was
reached because of severe difficulty recruiting partici-
pants. For the participants of the study, the burden was
high because of the frequent visits to the research unit
and regular blood sampling on those study visits. From
the 18 children that were included in the study, four
(22%) dropped out before the end of the study. Dropout
is a major concern in studies in children with obesity,
and dropout rates much higher than those in the present
study have been reported (41). All dropouts occurred
during the second half of the intervention, and all were
on the HP diet in this period. It cannot be ruled out that
the HP diet itself affected the motivation and willingness
to comply with the study requirements. However, there
was no indication that compliance to the HP supplements
decreased during the study period. During recruitment, a
lot of effort was put in including only those children and
parents who were highly motivated. Nevertheless, it
seems that during the study period, the motivation to
comply with the study requirements decreased. The
study did not aim to induce body-weight loss, but it was
expected that in such a highly motivated population, the
results would show a stabilization of BMI-SDS during
the study period. The fact that this did not happen shows
how difficult body-weight management is for children
with obesity. It may be speculated that the effect of the
diet that the children would experience was not as big
as the participants had hoped for and that this resulted
in a loss of motivation. The attention that was paid to
inclusion of only those children and parents who were
highly motivated may have resulted in a study population
that is not fully representative of the total population. This
should be taken into account when interpreting the
results for a broader audience. The number of subjects
in the study should also be seen in the light of the study
design and type of measurement. It was a crossover
study where the children were their own control, thereby
reducing the effect of confounding. In addition, for
measurements using stable isotope techniques, studies
with eight subjects are not uncommon (21). A major
strength of the study is the use of different types of
high-quality and well-validated techniques, like indirect
calorimetry, DEXA scanning and stable isotope tech-
niques to measure different outcomes relating to energy
and protein metabolism. These are costly and relatively
invasive techniques for children, adding to the unique-
ness of this study.
This study was designed to study the mechanistic
effects of an HP intake in children with obesity. It was hy-
pothesized that the HP supplements increased satiety,
resulting in a lower ad libitum food intake from the regular
diet. However, the results show that this was not the
case. The results show a small beneficial effect on FFM;
however, no effects on energy intake or energy
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expenditure were observed. Moreover, the BMI-SDS and
fat mass of the children significantly increased during the
study period, which indicates that the obesity became
worse during the study period. It needs further study
whether an HP intake may be supportive for children with
obesity in reducing hunger feelings and supporting FFM
when on a diet with a reduced energy content for weight
loss. In conclusion, a 4-week HP diet with ad libitum food
intake did not affect energy intake and energy expendi-
ture in children with obesity. BMI increased, although that
could be partly explained by an increase in FFM.
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